Article
Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.
Oncotarget - 22 Mar 2016
Messina Monica, Chiaretti Sabina, Wang Jiguang, Fedullo Anna Lucia, Peragine Nadia, Gianfelici Valentina, Piciocchi Alfonso, Brugnoletti Fulvia, Di Giacomo Filomena, Pauselli Simona, Holmes Antony B, Puzzolo Maria Cristina, Ceglie Giulia, Apicella Valerio, Mancini Marco, Te Kronnie Geertruy, Testi Anna Maria, Vitale Antonella, Vignetti Marco, Guarini Anna, Rabadan Raul, Foà Robin
Abstract excerpt
To shed light into the molecular bases of B-lineage acute lymphoblastic leukemia lacking known fusion transcripts, i.e. BCR-ABL1, ETV6-RUNX1, E2A-PBX1, and MLL rearrangements (B-NEG ALL) and the differences between children, adolescents/young adults (AYA) and adults, we analyzed 168 B-NEG ALLs by genome-wide technologies. This approach showed that B-NEG cases carry 10.5 mutations and 9.1 copy-number...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
